Dougherty & Co Starts CyberOptics (CYBE) at Buy
Get Alerts CYBE Hot Sheet
Rating Summary:
2 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 17
Join SI Premium – FREE
Dougherty & Co initiated coverage on CyberOptics (NASDAQ: CYBE) with a Buy rating and a price target of $27. Analyst Richard Ryan sees opportunity following the company's recent transformation.
"CyberOptics has gone through a multi-year transformation of moving into 3D inspection (from 2D) which is helping it break away from a decade old continuum. Through the use of its proprietary algorithms, CYBE is speeding up inspection in its legacy Surface Mount Technology (PCBs) and Semiconductor industries which are facing never-ending miniaturization of devices. Outside of 3D inspection, CYBE’s WaferSense offering keeps production tools running, thus increasing yields. WaferSense has no competition and extensive IP protection, creating an extremely solid base of business," said Ryan.
The analyst added, "As Non-Semiconductor manufacturing becomes sophisticated, 3D automatic optical inspection is opening many doors. For industrial/medical industries, it is paramount to inspect devices (against CAD specs) and detect defects early. CYBE’s 3D technology aids in eliminating rework and manufacturing delays at impressive speeds. This unlocks a massive opportunity for 3D Scanning which is a ~$3B+ industry and not in CYBE’s revenues."
For an analyst ratings summary and ratings history on CyberOptics click here. For more ratings news on CyberOptics click here.
Shares of CyberOptics closed at $21.68 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TD Cowen Resumes EQT Corp. (EQT) at Hold
- Prysmian SpA (PRY:IM) (PRYMY) PT Raised to EUR53 at HSBC
- London Stock Exchange Group Plc. (LSEG:LN) (LNSTY) PT Raised to GBP88 at HSBC
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS View, New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!